Sign In
Buy LNTH
$102.82
+2.57 (+2.56%)
At Close: Jun 04, 2026
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
05:31pm, Tuesday, 01'st Jun 2021
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive outcomes.
Lantheus Holdings (LNTH) Soars 16.8%: Is Further Upside Left in the Stock?
07:31am, Friday, 28'th May 2021
Lantheus Holdings (LNTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price incr
Why Lantheus Stock Is Soaring Today
11:45am, Thursday, 27'th May 2021
Investors are cheering FDA approval for the company's prostate cancer imaging agent.
LNTH Stock Price: Over 20% Increase Pre-Market Explanation
07:57am, Thursday, 27'th May 2021
The stock price of Lantheus Holdings Inc (NASDAQ: LNTH) increased by over 20% pre-market. This is why it happened.
Is the Options Market Predicting a Spike in Lantheus Holdings (LNTH) Stock?
10:32am, Monday, 24'th May 2021
Investors need to pay close attention to Lantheus Holdings (LNTH) stock based on the movements in the options market lately.
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2021 Results - Earnings Call Transcript
08:50am, Sunday, 09'th May 2021
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2021 Results - Earnings Call Transcript
Lantheus Expands R&D Leadership Team with Key New Hires
08:30am, Wednesday, 07'th Apr 2021
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics
LNTH Stock Price Increased 9.95%: Why It Happened
09:25pm, Tuesday, 30'th Mar 2021
The stock price of Lantheus Holdings Inc (NASDAQ: LNTH) increased by 9.95% today. This is why it happened.
Lantheus Holdings (LNTH) Enters Overbought Territory
09:50am, Tuesday, 23'rd Mar 2021
Lantheus Holdings (LNTH) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Lantheus Announces Publication of PyL™ (18F-DCFPyL) Results from Pivotal Studies
08:30am, Monday, 01'st Mar 2021
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q4 2020 Results - Earnings Call Transcript
06:22pm, Saturday, 27'th Feb 2021
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q4 2020 Results - Earnings Call Transcript
Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference
08:30am, Friday, 12'th Feb 2021
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics
Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting
08:30am, Thursday, 04'th Feb 2021
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a glo
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the Company), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI Di
